The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase
- Brent J. Passer*,†,
- Vanessa Nancy-Portebois*,†,
- Nathalie Amzallag*,†,
- Sylvie Prieur*,
- Christophe Cans*,
- Aude Roborel de Climens*,
- Giusy Fiucci*,
- Véronique Bouvard*,
- Marcel Tuynder*,
- Laurent Susini*,
- Stéphanie Morchoisne*,
- Virginie Crible*,
- Alexandra Lespagnol*,
- Jean Dausset‡,
- Moshe Oren§,
- Robert Amson*, and
- Adam Telerman*,¶
- *Molecular Engines Laboratories, 20 Rue Bouvier, 75011 Paris, France; ‡Fondation Jean Dausset–Centre d'Etude du Polymorphisme Humain, 27 Rue Juliette Dodu, 75010 Paris, France; and §Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel
-
Contributed by Jean Dausset
Abstract
The p53 tumor suppressor protein plays a crucial role in tumorigenesis by controlling cell-cycle progression and apoptosis. We have previously described a transcript designated tumor suppressor activated pathway-6 (TSAP6) that is up-regulated in the p53-inducible cell line, LTR6. Cloning of the murine and human full-length TSAP6 cDNA revealed that it encodes a 488-aa protein with five to six transmembrane domains. This gene is the murine and human homologue of the recently published rat pHyde. Antibodies raised against murine and human TSAP6 recognize a 50- to 55-kDa band induced by p53. Analysis of the TSAP6 promoter identified a functional p53-responsive element. Functional studies demonstrated that TSAP6 antisense cDNA diminished levels of the 50- to 55-kDa protein and decreased significantly the levels of p53-induced apoptosis. Furthermore, TSAP6 small interfering RNA inhibited apoptosis in TSAP6-overexpressing cells. Yeast two-hybrid analysis followed by GST/in vitro-transcribed/translated pull-down assays and in vivo coimmunoprecipitations revealed that TSAP6 associated with Nix, a proapoptotic Bcl-2-related protein and the Myt1 kinase, a negative regulator of the G2/M transition. Moreover, TSAP6 enhanced the susceptibility of cells to apoptosis and cooperated with Nix to exacerbate this effect. Cell-cycle studies indicated that TSAP6 could augment Myt1 activity. Overall, these data suggest that TSAP6 may act downstream to p53 to interface apoptosis and cell-cycle progression.
Footnotes
-
↵ † B.J.P., V.N.-P., and N.A. contributed equally to this work.
-
↵ ¶ To whom correspondence should be addressed. E-mail: atelerman{at}molecular-engines.com.
-
Data deposition: The sequences reported in this paper have been deposited in the GenBank database [accession nos. AY214462 (murine TSAP6) and AY214461 (human TSAP6)].
- Abbreviations:
- TSAP,
- tumor suppressor activated pathway;
- HA,
- hemagglutinin;
- Y2H,
- yeast two-hybrid;
- IVT,
- in vitro-transcribed/translated;
- siRNA,
- small interfering RNA;
- DTB,
- double-thymidine block;
- PARP,
- poly(ADP-ribose) polymerase;
- AIP,
- apoptosis-linked gene-2-interacting protein 1
- Copyright © 2003, The National Academy of Sciences





